
Venture investor backing technology, biotech and healthcare companies from biology tools to satellites

Venture investor in science, health and software companies including biotech and satellite ventures

Rising Tide is a venture investor that backs companies in biology, healthcare and related science, and a good part of its public writing explains why each of these businesses matters. The portfolio pages group companies under headings such as Biology and Life Sciences and Healthcare and Medical Devices, and a partner posts short notes on new investments that set out the problem a company is attacking and the technology behind it.
Several holdings work on the basic tools of biology. One company is developing a radically different approach to gene synthesis, and another is building enzymatic DNA synthesis technology to power DNA-based products. A third is building an artificial intelligence enhanced platform that engineers synthetic molecules designed to mimic the macrocycles found in nature, aiming to create entirely new drugs. A fourth, based in Cambridge, Massachusetts, is clinical-stage and studies the microbes found on fresh produce in the search for treatments for inflammation linked to aging, including the mycobiome as a new class of probiotics.
Another portfolio company combines microfluidics with 3D bioprinting to develop bioprinted tissue therapeutics. A surgical technology business is building a hardware-agnostic platform for autonomous and collaborative surgery. A medical imaging company, Exo Imaging, supplies imaging and therapeutic tools intended to help clinicians make decisions that save lives, and the firm has promoted its work at a healthcare event.
The firm's interests reach into chemistry and the climate. One company turns carbon dioxide into essential products using electrochemistry, a route the firm presents as a way to cut emissions while making something useful. Another portfolio company puts a corporate credit card in the hands of start-ups in emerging markets.
Each Our Investment note names the sector and the thesis in its title, so a reader can see quickly where money has been placed and the reasoning behind it, rather than reading only a list of logos.
Rising Tide is a venture investor with a portfolio spanning biology, healthcare and software. Its principal Brent MacDonald writes short notes about its investments, and its site groups companies by sector.
Founders building science-led and software companies, including a carbon-transformation venture.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Rising Tide (company).
Similar listings buyers compare against this one.

Venture investor backing technology, biotech and healthcare companies from biology tools to satellites

Investor in software-led teams aiming to automate large parts of the world across any sector or country

Technology investment bank and growth investor covering software, fintech, digital media and commerce

Crypto and blockchain investor backing multi-stage Web3 companies worldwide, part of CTH

Global venture capital partnership investing in data, technology and analytics companies, backed by RELX Group

Oregon venture capital fund investing early in minority and women-led startups

Venture firm investing in tech startups and building their engineering teams in Latin America

Small venture firm that works closely with early-stage founders from the earliest stage
Everything here links back to the same verified catalogue. Pick your next stop.